Print page Share page

Committed to excellence in governance.

The ARIAD Board of Directors is a team of experienced, respected business leaders, committed to the highest standards of corporate governance, sound business practices and financial transparency.

Board of directors

Harvey J. Berger, M.D.
Chairman and Chief Executive Officer, ARIAD Pharmaceuticals, Inc.

Jay R. LaMarche
Former Executive Vice President, Chief Financial Officer and Treasurer, ARIAD Pharmaceuticals, Inc.

Alexander J. Denner, Ph.D.
Founding Partner, Sarissa Capital Management

Athanase Lavidas, Ph.D.
Chairman and Chief Executive Officer, Lavipharm Group

Anna Protopapas
Chief Executive Officer, Mersana Therapeutics

Massimo Radaelli, Ph.D.
Chairman and Chief Executive Officer of Bioakos Pharma

Norbert G. Riedel, Ph.D.
President and Chief Executive Officer, Naurex, Inc.

Sarah J. Schlesinger, M.D.
Senior Attending Physician and Associate Professor of Clinical Investigation, The Rockefeller University

Wayne Wilson
Independent Business Advisor and Lead Director, ARIAD Pharmaceuticals, Inc.

You are now leaving this website. If you would like to continue, click Continue.